Scleral Allografting and Amniotic Membrane Transplantation With Fibrin Glue in the Management of Scleromalacia
Journal of the Korean Ophthalmological Society
;
: 485-491, 2010.
Artigo
em Coreano
| WPRIM
| ID: wpr-105767
ABSTRACT
PURPOSE:
To examine the effects, complications, and safeties of sclera allograft and amniotic membrane transplantation with fibrin glue as surgical treatment methods for scleromalacia.METHODS:
The study included 14 eyes of 14 scleromalacia patients who needed surgical treatment. Among them, seven eyes of seven patients whose scleral defect was small (6 mm) were operated on using fibrin glue and minimum suturing. Amniotic membrane transplantation was performed at the site of the conjunctival defect.RESULTS:
In all of the cases, the results of grafting were successful throughout the follow-up period, which was 14.6+/-4.4 months, on average (ranging from 12 to 27 months). No particular complication was observed during the follow-up period after using fibrin glue.CONCLUSIONS:
For scleromalacia patients, sclera allograft and amniotic membrane transplantation were performed using fibrin glue. The grafted sclera survived successfully, allowing this treatment modality to be considered an effective and safe option without complications.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Segurança
/
Esclera
/
Transplante Homólogo
/
Fibrina
/
Adesivo Tecidual de Fibrina
/
Seguimentos
/
Transplantes
/
Olho
/
Âmnio
Tipo de estudo:
Estudo observacional
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Ano de publicação:
2010
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS